Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Verve Therapeutics
26 Landsdowne Street, 1st Floor
Cambridge, MA 02139
Phone: 617-603-0070

Verve Therapeutics is a biotechnology company created with a singular focus: to protect the world from heart disease. Verve is developing therapies to safely edit the genome of adults and confer lifelong protection from coronary artery disease, the most common form of heart disease and the leading cause of death worldwide. Founded by world-leading experts in cardiovascular medicine and gene editing, Verve is backed by a top-tier syndicate of investors, including GV (formerly Google Ventures), ARCH Venture Partners, F-Prime Capital, and Biomatics Capital. Verve is headquartered in Cambridge, Massachusetts, and has a research lab located at Pennovation Works, the University of Pennsylvania incubator space in Philadelphia.

Key Contact
Sekar Kathiresan, M.D.
Funding Events

05/07/19 $58,500,000 Series A ARCH Venture Partners
Biomatics Capital
F-Prime Capital Partners
06/11/20 $63,000,000 Series A-2 ARCH Venture Partners
Biomatics Capital
Casdin Capital
F-Prime Capital Partners
Wellington Capital Management
01/19/21 $94,000,000 Series B Biomatics Capital
Casdin Capital
Cormorant Asset Management
Janus Henderson Investors
Logos Capital
Novo Holdings
RA Capital Management
Redmile Group
Rock Springs Capital
Surveyor Capital
Wellington Capital Management

Featured Reading